Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease

Journal of Medical Virology

Volumn 52, Issue 2, 1997, Pages 215-218

  Lee, Shou Dong ^a   Chan, Cho Yu ^a   Yu, May Ing ^a   Wang, Yuan Jen ^a   Chang, Full Young ^a   Lo, Kwang Juei ^a   Safary, Assad ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b Clinical Research Center   (Belgium)

Author keywords

Chronic liver disease; Inactivated hepatitis A vaccine; Viral hepatitis

Indexed keywords

HEPATITIS A VACCINE; HM 175; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BELGIUM; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HEPATITIS A VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MALE;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; VACCINES, INACTIVATED; VIRAL HEPATITIS VACCINES;

HEPATITIS A VIRUS; HEPATITIS C VIRUS;

EID: 0030927093     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199706)52:2<215::AID-JMV16>3.0.CO;2-J     Document Type: Article

References (16)

1. Akriviadis EA, Redeker AG (1989): Fulminant hepatitis A in intravenous drug users with chronic liver disease. Annals of Internal Medicine 110:838-839.
2. Andre FE, Hepburn A, D'Hondt E (1990): Inactivated candidate vaccines for hepatitis A. Progress in Medical Virology 37:72-95.
3. Briem H, Safary A (1994): Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later. Journal of Medical Virology 44:443-445.
4. Crosnier J, Jungers P, Courouce AM, Laplanche A, Benhamou E, Degos F, Lacoor B, Prunet P, Cerisier Y, Guesry P (1981): Randomized placebo controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units. II. Haemodialysis patients. Lancet 1:797-800.
5. Feray C, Gigou M, Samuel D, Reyes G, Bernuau J, Reyes M, Bismuth H (1993): Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 104:549-555.
6. Hadler SC (1991): Global impact of hepatitis A virus infection -changing patterns. In Hollinger FB, Lemon SM, Margolis HS (eds): "Viral Hepatitis and Liver Disease." Baltimore: Williams and Wilkins, pp 14-19.
7. Hess G, Clemens R, Bienzle U, Schonfeld C, Schunck B, Bock H-L (1995): Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual men. Journal of Medical Virology 46:40-42.
8. Keet IPM, van Doorum G, Safary A, Coutinho RA (1992): Insufficient response to hepatitis B vaccination in HIV-positive homosexual men. Acquired Immune Deficiency Syndrome 6:509-510.
9. Lee SD, Lo KJ, Chan CY, Yu MY, Wang YJ, Safary A ( 1993): Immunogenicity of inactivated hepatitis A vaccine in children. Gastroenterology 104:1129-1132.
10. Lee SD, Chan CY, Yu MI, Wang YJ, Lo KJ, Safary A (1996): Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters. American Journal of Gastroenterology 91:1360-1362.
11. Thomas HC, Brown D, Routhier G, Janossy G, Kung PC, Goldstein G, Sherlock S (1982): Inducer and suppressor T-cells in hepatitis B virus-induced liver disease. Hepatology 2:202-204.
12. Wang JY, Lee SD, Tsai YT, Lo KJ, Chiang BN (1986): Fulminant hepatitis A in chronic HBV carrier. Digestive Diseases and Science 31:109-111.
13. Weizberger A, Mensch B, Kuter B, Brown L,. Lewis J, Sitrin R, Miller W, Shouval D, Wiens B, Calandra G, Ryan J, Provost P, Nalin D (1992): A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. New England Journal of Medicine 327: 453-457.
14. Wu JC, Chen CL, Hou MC, Chen TZ, Lee SD, Lo KJ (1994): Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: Application and limitation of the polymerase chain reaction. Hepatology 19:836-840.
15. Yao G (1991): Clinical spectrum and natural history of viral hepatitis A in a 1988 Shanghai epidemic. In Hollinger FB, Lemon SM, Margolis HS (eds): "Viral Hepatitis and Liver Disease." Baltimore: Williams and Wilkins, pp 76-78.
16. Zuckerman JN, Moore S, Smith J, Tyrrell H, Baxter A, Lee CA (1996): A study to assess the immunogenicity, reactogenicity and safety of hepatitis A vaccine administered subcutaneously to patients with congenital coagulation disorders. Haemophilia 2:235-239.